Saad Z. Usmani, MD, MBA, FACP, discusses how the definition of the transplant-ineligible population for multiple myeloma is evolving while also addressing the challenges of standardizing minimal ...

The Head and Neck Radiation Oncology Group (GORTEC) announced significant improvement in disease-free survival for locally ...

A team of researchers from the Translational Oncology Research Centre (TORC) of Vrije Universiteit Brussel (VUB), in ...

For patients with relapsed or refractory multiple myeloma, talquetamab plus teclistamab shows response in a high percentage ...

A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...

The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.

Researchers conducted an analysis of how NCCN guidelines for myeloma treatment are updated, offering suggestions for a more standardized process.

Meet Dr. David Chung, Northwell Health's newest cancer care specialist. Learn about his priorities, challenges, and vision for personalized treatments ...

The trial enrolled 531 adult subjects with multiple myeloma who had received at least one previous line of therapy.

When multiple myeloma comes back you are going to face decisions about which treatment to choose because there is no single standard of care. We’ve created a series of videos to help you in this ...

Jan. 6, 2025 — People who care for both their children and older family members -- also known as 'sandwich carers' -- suffer from deterioration in both their mental and physical health over time ...